Alaunos Therapeutics Inc. – Credit Agreements Watch

from 8-K 24 pages Neither This Security Nor the Securities as to Which This Security May Be Exercised Have Been Registered With the Securities and Exchange Commission or the Securities Commission of Any State in Reliance Upon an Exemption From Registration Under the Securities Act of 1933, as Amended (The “Securities Act”), And, Accordingly, May Not Be Offered or Sold Except Pursuant to an Effective Registration Statement Under the Securities Act or Pursuant to an Available Exemption From, or in a Transaction Not Subject To, the Registration Requirements of the Securities Act and in Accordance With Applicable State Securities Laws as Evidenced by a Legal Opinion of Counsel to the Transferor to Such Effect. This Security and the Securities Issuable Upon Exercise of This Security May Be Pledged in Connection With a Bona Fide Margin Account or Other Loan Secured by Such Securities. Common Stock Purchase Warrant Alaunos Therapeutics, Inc. Warrant Shares: 79,900 Date of Issuance: May 19, 2025

from 10-K 12 pages First Amendment to Loan and Security Agreement

from 10-Q 60 pages Loan and Security Agreement